Echo IQ (ASX:EIQ) has entered into a strategic partnership and integration agreements with two US healthcare technology providers, ScImage and MedAxiom, to expand the distribution of its artificial intelligence-powered cardiology tool, EchoSolv AS, according to a Monday filing with the Australian bourse.
The integration will provide physicians with access to advanced diagnostics via ScImage's image management platform, the filing said.
Shares of the company fell 3% in recent Monday trade.